Canceled AdCom, UniQure’s Hemgenix Approval Show Positive Signs For BioMarin’s Hemophilia Candidate
Earlier today, the FDA notified BioMarin Pharmaceutical Inc (NASDAQ:BMRN) that the agency no longer plans to hold an advisory committee meeting to…